1-2 of 2
Caroline Robb
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RPT1G, a novel hyperbolic NAMPT inhibitor, is highly effective against B-cell non-Hodgkin's lymphoma with germinal center origin

Free
Michael Schelle, Min Wu, Francis Roushar, Timothy Jarvela, Caroline Robb, Banumathi Cole, Dennise De Jesús-Díaz, Gregory Crimmins
Journal: Blood
Blood (2025) 146 (Supplement 1): 5080.
https://doi.org/10.1182/blood-2025-5080
Published: 2025
Journal Articles

First-in-human randomized placebo-controlled Phase 1 study of RPT1G, a novel hyperbolic NAMPT inhibitor for use in acute leukemias: Safety, pharmacokinetics, and pharmacodynamics in healthy volunteers

Free
Gregory Crimmins, Thomas Polasek, Caroline Robb, Srikanth Pendyala, Michael Schelle, Timothy Jarvela, Banumathi Cole, Min Wu, Kelechi Joe-Nweke, Dennise De Jesús-Díaz
Journal: Blood
Blood (2025) 146 (Supplement 1): 5044.
https://doi.org/10.1182/blood-2025-5044
Published: 2025